Relmada Therapeutics RLMD
NASDAQ RLMD
$4.43 +0.16 (+3.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Relmada Therapeutics (RLMD) Change in Acquisitions & Divestments (2020)

Updated

Relmada Therapeutics (RLMD) recorded Change in Acquisitions & Divestments of -$75.96 million in Q2 2020.

Analysis

Relmada Therapeutics (RLMD) Change in Acquisitions & Divestments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Relmada Therapeutics 455.48 Mn -103.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -75.96 Mn
Mar 31, 2020 13.60 Mn
API Access

Relmada Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=RLMD&period=max&api_key=YOUR_API_KEY